
Excessive sweating affects 1-5% of the population and can have a substantial impact on quality of life

A record two million women were prescribed hormone replacement therapy in 2025/26 compared to 0.8 million in 2020/21

Against the backdrop of widespread medicine shortages, Durbin PLC’s rebrand to Uniphar and integration into Uniphar | Global Sourcing represents a strategic move to address industry-wide challenges, expanding its sourcing...

The data underlines the consequences of disrupted sleep for patients and caregivers

This is the first approved treatment option in the UK for patients with non-segmental vitiligo

EpilepsyMeds received Highly Commended recognition at the Excellence in Healthcare Partnership Awards 2026, celebrating the collaboration between Desitin Pharma, ChangeMed and Genetic Digital in advancing epilepsy care.

US tariffs on UK-produced pharmaceuticals will remain at zero for three years

The study demonstrated a sustained reduction in seizures for patients

The treatment is the first and only long-acting HIV prevention option available on the NHS in England and Wales

The Commission will unite healthcare leaders, regulators and technology experts to shape future AI governance

Genetic Digital wins Silver at the PM Society Digital Awards for Epilepsy Meds, a clinical support app developed with Desitin and ChangeMed to aid patient-specific prescribing in epilepsy care.

The US-based company develops light-based therapies for neurodegenerative conditions